Advanced Cellular Dynamics, Inc.

Founded in 2004, Pharmaron is a cutting-edge, fully integrated pharmaceutical R&D service platform supporting the life science industry. The company has invested in its people and facilities and established its comprehensive service offerings throughout the pharmaceutical R&D lifecycle. With operations in China, the US and the UK staffed by more than 11,000 employees, Pharmaron has an excellent track record in delivering end-to-end R&D solutions to its partners globally and enabling them to accelerate their novel drug discovery and development process.

Pharmaron is a contract research organization (CRO).

Services:
* Synthetic, medicinal and analytical chemistry services
* Biology services
* DMPK services
* Pharmacology services
* Drug safety assessment services
* Radiochemistry and isotopically labelled metabolism services
* Chemical & pharmaceutical development services
* Clinical development services

www.pharmaron.com

CRO - Contract Research Organization
Library Synthesis
CADD
Bioorganic Chemistry
Discovery Process Chemistry
Radiolabelled Chemical Synthesis
ChemInformatics
in vitro Biology
in vitro Screening
Structural Biology
in vivo Pharmacology
Animal Disease Models
ex vivo Pharmacology
Biomarkers
in vitro ADME
in vivo PK
PKPD
QA
Regulatory Affairs
Discovery Biologics
Process Chemistry
API Manufacturing
Material Science
Formulation Development
Drug Product Manufacturing
Toxicology
Safety Pharmacology
Genetic Toxicology
DART
Pathology
Immunotoxicity
Bioanalytical
14C / Carbon-14 Radiosynthesis
3H / Tritium Radiosynthesis
QWBA
mARG
Clinical AME
Mass Balance
Metabolite Profiling
Microdosing Phase 0
Absolute Bioavailability
DDI
First-in-Human (FIH)
Thorough QT(TQT)
Ethnobridging

Cellworks is a world leader in Precision Medicine. We help physicians and payers navigate to the most efficacious, cost-effective treatments for patients in a transparent and timely manner. Cellworks’ key therapeutic areas are Oncology, Immunology, Dermatology and Infectious Diseases. Cellworks’ unique bio-simulation platform is a unified representation of biological knowledge, curated from heterogeneous datasets, applied to finding cure. Since 2005, backed by Artiman Ventures and Sequoia Capital, Cellworks has the world’s strongest trans-disciplinary team of molecular biologists, cellular pathway modelers, and internet software technologists working towards a common goal – attacking serious diseases to improve the lives of patients.

Invivotek LLC, a member of Genesis Biotechnology Group® (GBG) is a global pre-clinical contract research organization (CRO) specializing in small animal studies for drug discovery and early optimization. Invivotek's facility was opened in 2012 and our first commercial project launched in 2013.

Invivotek offers both custom and standard pre-clinical services for drug discovery and development programs for our clients. Invivotek’s portfolio includes animal models and bioassays designed to support in vivo testing of compounds related to Immunology and Inflammation, Oncology, Metabolic, and Cardiovascular diseases. Invivotek’s in vivo testing capabilities are supported by biochemical and molecular biology techniques as well as functional assays with primary cell cultures established from various mouse tissues under disease model and normal conditions. These assays provide tools to study the mechanism of action of various test therapeutics or potential target genes and to explore drug efficacy biomarkers. The collective experience across multiple therapeutic areas in conjunction with the business and project management skills of the team working in a state-of-the-art animal facility, position Invivotek as a leading provider of preclinical in vivo services.

MBL International Corporation (MBLI) is a leading life science company focused on providing solutions for researchers in the life sciences, drug discovery and development and clinical diagnostics fields. Our special emphasis is on immunology, immuno-oncology, oncology and autoimmune disease areas. As a JSR Life Sciences Company, MBLI is committed to improve the probability of success, decrease timelines, and increase the efficacy of biologics-based therapies for the benefit of patients.

Our products are used widely in academic research and medical institutions, pharmaceutical and biotechnology companies, government agencies as well as hospital and reference laboratories. We are focused on developing high quality products and have high standards for quality control in our manufacturing process. Our products include MHC monomers and multimers, antibodies, recombinant proteins, fluorescent proteins, and ELISA kits. Our products are highly cited and support numerous research fields relating to oncology, allergy, apoptosis, autophagy, epigenetics and neuroscience.

MBLI is known for its line of immune monitoring reagents, including MHC Tetramers and Monomers, as well as our line of QuickSwitch™ products for screening peptides and neoantigens. We help researchers to acquire reliable and reproducible immune monitoring results for the areas of immuno-oncology, autoimmune, vaccine development and more.

MBLI is committed to increasing the efficiency and effectiveness of its customers’ science by delivering quality products with uncompromising support through our scientific sales, customer service, and technical support teams. Our goal is to ensure that our customers get the products and assistance when they need it.

Headquartered in Woburn, MA, with a manufacturing location in Des Plaines, IL, MBLI’s extens

Contact MBL International today to learn more about how we can help you discover ways to make your science more efficient and effective. Contact sales@mblintl.com

ProteoGenex is an established, innovative provider of biological specimens and clinical information of the highest quality standards.

We are a privately held US company founded in Los Angeles, CA in 2003. With headquarters in Culver City, CA, we also have a large, state-of-the-art research laboratory in Moscow, Russia.

The ProteoGenex team consists of 35 employees, including 30 Molecular Biologists, Cell Biologists, Biochemists, and Pathologists (15 PhDs, 5 MDs, 15 MSs).

Our biorepository offers an extensive inventory of biospecimens as well as an exclusive, custom-design human tissue-based research service, which is the company’s largest and fastest growing business segment.
Our unique and comprehensive biobank is composed of well-defined and categorized clinical samples, including frozen and FFPE tissues, blood, serum, plasma, bone marrow, tissue microarrays, etc. All ProteoGenex specimens are collected from a vast network of academic and professional clinical institutions under strict regulatory and ethical standards.

We have over 200,000 individual biomaterials covering disease targets in the fields of Oncology, Dermatology, Neurology, Immunology, Infectious Diseases, Autoimmune and Metabolic Disorders, and many more. Our products are derived from a variety of diseased human sources as well as from normal tissues. All specimens are supported by extensive pathology information and patient’s’ clinical history documentation.